Lebanon, New Hampshire 03756


Purpose:

To study if incisional vacuum-assisted closure can decrease the risk of infection in cesarean section incisions in the obese compared with standard sterile dressing.


Study summary:

The prevalence of obesity (defined as body mass index (BMI, kg/m2) ≥ 30) has significantly increased, affecting approximately 35% of adult females in the United States, according to CDC 2009-2010 statistics. Obesity has a significant impact on pregnancy, including increased need for cesarean section and post-operative wound complications. Infection rates have been reported to be between 10 and 30%. The advent in 1997 of negative pressure therapy (NPT), also known as vacuum assisted closure (VAC), has vastly changed wound care management. Briefly, VAC has been traditionally applied to a chronic wound to create negative or sub-atmospheric pressure, thus promoting wound healing by decreasing edema and increasing blood flow and formation of granulation tissue. Use of this therapy at the time of primary closure of a surgical incision (first trialed in 2006 and termed "Incisional VAC") has provided a promising approach to reducing post-operative wound infection. Incisional VAC has been explored primarily in the orthopedic and cardiothoracic fields, but very few studies have examined the use on abdominal incisions, and only one to date on cesarean section incisions.


Criteria:

Inclusion Criteria: - Patients that have undergone cesarean section for delivery; have a BMI greater or equal to 35. All cases of cesarean section including primary and repeat, scheduled and urgent. Exclusion Criteria: - Patients who deliver vaginally; age less than 18 years old; silver allergy; non-English speaking


NCT ID:

NCT02390401


Primary Contact:

Principal Investigator
Zachary Spalding, MD
Dartmouth-Hitchcock Medical Center

Zachary Spalding, MD
Phone: 603-653-9300
Email: Zachary.T.Spalding@hitchcock.org


Backup Contact:

Email: Ellen.M.Joyce@hitchcock.org
Ellen Joyce
Phone: 603-653-9300


Location Contact:

Lebanon, New Hampshire 03756
United States

Zachary Spalding, MD
Phone: 603-653-9300
Email: Zachary.T.Spalding@hitchcock.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.